A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Pembrolizumab with sacituzumab govitecan instead of chemotherapy led to improved progression-free survival in PD-L1-postive ...

A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy ...

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line ...

A party is planned to celebrate the end of a year of chemotherapy for a brave Teesside youngster who is battling brain cancer ...

The treatment could also delay the need for gruelling chemotherapy, according to the trial. | ITV National News ...

Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an aggressive ...

A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

Early in his career, Francesco Acerbi overcame alcoholism, depression and cancer twice. Now, at 37, he is Champions League ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.